Natixis Investment Managers International’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.44M | Sell |
19,426
-1,050
| -5% | -$77.7K | 0.11% | 62 |
|
|
2024
Q3 | $1.35M | Buy |
20,476
+11,260
| +122% | +$743K | 0.1% | 62 |
|
|
2024
Q2 | $851K | Sell |
9,216
-350
| -4% | -$32.3K | 0.06% | 73 |
|
|
2024
Q1 | $914K | Sell |
9,566
-422
| -4% | -$40.3K | 0.06% | 74 |
|
|
2023
Q4 | $762K | Sell |
9,988
-48
| -0.5% | -$3.66K | 0.05% | 87 |
|
|
2023
Q3 | $695K | Sell |
10,036
-278
| -3% | -$19.3K | 0.05% | 84 |
|
|
2023
Q2 | $973K | Buy |
10,314
+336
| +3% | +$31.7K | 0.07% | 76 |
|
|
2023
Q1 | $825K | Sell |
9,978
-642
| -6% | -$53.1K | 0.06% | 82 |
|
|
2022
Q4 | $792K | Hold |
10,620
| – | – | 0.06% | 86 |
|
|
2022
Q3 | $877K | Sell |
10,620
-15,034
| -59% | -$1.24M | 0.07% | 75 |
|
|
2022
Q2 | $2.44M | Buy |
25,654
+17,767
| +225% | +$1.69M | 0.05% | 109 |
|
|
2022
Q1 | $928K | Buy |
+7,887
| New | +$928K | 0.02% | 227 |
|
|
2018
Q4 | – | Sell |
-27,708
| Closed | -$1.61M | – | 211 |
|
|
2018
Q3 | $1.61M | Buy |
27,708
+3,636
| +15% | +$211K | 0.08% | 248 |
|
|
2018
Q2 | $1.17M | Buy |
+24,072
| New | +$1.17M | 0.06% | 231 |
|
|
2017
Q4 | – | Sell |
-13,131
| Closed | -$478K | – | 235 |
|
|
2017
Q3 | $478K | Buy |
+13,131
| New | +$478K | 0.04% | 269 |
|
|
2016
Q4 | – | Sell |
-56,166
| Closed | -$2.26M | – | 431 |
|
|
2016
Q3 | $2.26M | Buy |
56,166
+564
| +1% | +$22.7K | 0.23% | 67 |
|
|
2016
Q2 | $1.85M | Sell |
55,602
-24,378
| -30% | -$811K | 0.2% | 69 |
|
|
2016
Q1 | $2.35M | Buy |
79,980
+45,918
| +135% | +$1.35M | 0.28% | 58 |
|
|
2015
Q4 | $897K | Sell |
34,062
-34,002
| -50% | -$895K | 0.12% | 102 |
|
|
2015
Q3 | $1.61M | Buy |
68,064
+2,040
| +3% | +$48.3K | 0.22% | 75 |
|
|
2015
Q2 | $1.57M | Buy |
66,024
+8,346
| +14% | +$198K | 0.19% | 85 |
|
|
2015
Q1 | $1.37M | Buy |
57,678
+50,076
| +659% | +$1.19M | 0.17% | 84 |
|
|
2014
Q4 | $161K | Buy |
+7,602
| New | +$161K | 0.02% | 285 |
|